Belviq, a weight loss drug used to treat obesity, has been recalled by the FDA The drug’s manufacturer, Esai Inc, has pulled the drug from the market as of February 2020.
After a five year study by the FDA it was found that Belviq is linked to an increased risk of cancers. Those cancers include:
The FDA recommends that people prescribed Belviq cease use immediately. The medication also presents numerous other health risks including:
If you or a loved one have used Belviq and now suffer from any of these issues, you must act quickly to get the compensation you deserve. Call 1-800-LundyLaw today.
Cases may be referred to associated law firms.